Japanese authorities define the scope of a drug quality audit by evaluating compliance with Good Manufacturing Practices (GMP), assessing production processes, quality control systems, documentation, and personnel training. The audit ensures that drugs meet safety, efficacy, and quality standards, aligning with the Pharmaceutical and Medical Device Act and related guidelines.